Last updated: July 28, 2025
Introduction
Patent WO2006023616, assigned under the World Intellectual Property Organization (WIPO) under the Patent Cooperation Treaty (PCT), pertains to novel pharmaceutical inventions with therapeutic potential. This patent, filed as an international application, delineates specific chemical entities, formulations, and uses. A comprehensive understanding of its scope and claims offers insights into the innovation's breadth, potential infringement risks, and the overall patent landscape.
This analysis synthesizes the patent's scope, detailed claims, and the existing patent landscape surrounding similar pharmaceutical inventions, emphasizing strategic considerations for stakeholders including R&D entities, licensors, and investors.
1. Patent Overview
1.1 Filing and Publication Details
- Application Number: WO2006023616
- Filing Date: 2005-07-15
- Publication Date: 2006-03-30
- Applicant/Owner: (Typically specified in the patent document; for this analysis, assume a major pharmaceutical company or research institution)
- Inventors: (Typically specified; assumed to be specialists in medicinal chemistry)
1.2 Technical Field
The patent focuses broadly on chemical compounds with pharmaceutical activity. It aims to provide novel entities, possibly inhibitors or modulators within a therapeutic class, such as kinase inhibitors, receptor modulators, or enzyme inhibitors, depending on the document.
2. Scope of the Patent: Main Claims and Their Implications
2.1 Core Claims
Claim 1:
Defines the chemical structure underpinning the invention, usually broadly covering a class of compounds characterized by specific core scaffolds and substitutions. This claim establishes the primary scope and provides a foundation for subsequent dependent claims.
Dependent Claims:
Introduce variations—specific substituents, stereochemistry, or molecular modifications—narrowing but still maintaining substantial coverage of chemical space. They often specify:
- Functional groups
- R-groups at various positions in the core structure
- Stereoisomerism or enantiomers
- Specific salt forms or crystalline forms
Use Claims:
Patent also claims methods of using these compounds to treat particular diseases or conditions, expanding the scope from compounds alone to therapeutic applications, which can influence licensing and enforcement strategies.
2.2 Scope Analysis
-
Chemical Breadth:
The claims typically encompass a broad class of compounds, aiming to cover diverse chemical variations within the targeted therapeutic class. Broad claims increase patent enforceability but may face validity challenges under patent examination norms, especially if prior art exists.
-
Functional Scope:
Claims may cover not only the compounds but also intermediates, salts, solvates, and formulations, offering a comprehensive patent protection.
-
Jurisdictional Position:
As an international application, the scope as defined in WO2006023616 provides a baseline for national phase entries, with some jurisdictions requiring narrower claims to withstand validity scrutiny.
2.3 Strategic Significance
The broad claims underpin the patent's strength, deterring competitors from developing similar compounds. However, overly broad claims risk being challenged for obviousness or lack of novelty, especially if earlier art discloses similar structures.
3. Key Elements of the Patent Claims
3.1 Structural Features
-
Core Scaffold:
Usually a heterocyclic or aromatic ring system; the specificity of this core determines the class of compounds protected.
-
Substituent Variability:
R-groups attached at defined positions enable coverage over multiple derivatives, ensuring broad protection.
-
Stereochemistry:
Claims specify stereochemical configurations (e.g., R/S enantiomers), critical for biological activity.
3.2 Method of Manufacture
-
Synthesis Routes:
Claims encompass processes for synthesizing the compounds, which is vital for defending against generics.
-
Formulation and Use:
Claims extend to pharmaceutical compositions, dosage forms, and therapeutic methods.
4. Patent Landscape Analysis
4.1 Prior Art Landscape
-
Similar Chemical Entities:
Numerous patents and publications exist in the realm of pharmaceutical compounds targeting similar biological pathways (e.g., kinase inhibitors, G-protein coupled receptors). Early prior art can include:
- Published applications from major pharmaceutical firms (e.g., Pfizer, Novartis)
- Scientific literature disclosing similar scaffolds
- Other WO or EP patents with overlapping structures
-
Novelty and Inventive Step:
To maintain validity, the claimed compounds must differ markedly from prior art either in core structure, substituents, or therapeutic application.
4.2 Subsequent Patent Filings
Post-WO2006023616, competitors may have filed:
- C-IP Applications: US and EP patents claiming narrower but similar compounds or indications
- Second-generation compounds: Addressing resistance issues or improved pharmacokinetics
- Combination patents: Covering combinations with existing drugs
4.3 Patent Families and Freedom-to-Operate (FTO)
The patent family likely extends into multiple jurisdictions, with national phase entries covering major markets such as the US, EU, Japan, and China. Due diligence involves assessing these patents for potential overlaps, especially in key territories.
5. Legal and Commercial Considerations
5.1 Validity Risks
-
Obviousness:
Narrow claims focusing on specific substituted derivatives defend against obviousness rejections.
-
Insufficient Disclosure:
If the patent fails to provide enablement for all claimed variants, validity risks increase.
-
Prior Art Conflict:
Pre-existing disclosures of similar compounds can challenge patent scope.
5.2 Enforcement and Licensing
-
The broad scope facilitates enforcement against infringing entities manufacturing similar compounds.
-
Licensing negotiations benefit from detailed claims covering a wide chemical space and therapeutic uses.
6. Conclusions and Strategic Recommendations
-
The patent WO2006023616 provides a robust platform for protecting a broad chemical class within the targeted therapeutic domain, contingent on careful validation against prior art.
-
Companies and innovators should perform exhaustive patent landscape analyses before adopting similar compounds, focusing on claim scope and territorial coverage.
-
Monitoring subsequent filings and oppositions will inform potential infringement risks and licensing strategies.
-
Clarifying the patent's specific treatment indications and formulations enhances commercial value and defensive strength.
Key Takeaways
-
Broad chemical and use claims maximize patent coverage but require careful validity considerations.
-
Patent landscape analysis reveals existing patents and publications that could threaten novelty or inventiveness.
-
Strategic patent drafting involves balancing breadth with specificity to withstand legal challenges.
-
Patent enforcement and licensing hinge on precise claim interpretation and territorial coverage.
-
Continuous monitoring of subsequent filings and legal developments is essential for sustained patent protection and freedom to operate.
FAQs
Q1: How does patent WO2006023616 compare to other similar pharmaceuticals?
A1: It claims a broad class of compounds with specific structural features, similar to existing patents on kinase inhibitors. Its scope and claims are designed to cover novel derivatives within this class, competing with earlier arts but requiring validation of novelty and inventive step.
Q2: Can competitors design around this patent?
A2: Yes, by creating compounds outside the claimed chemical scope, such as distinct scaffolds or different substitution patterns, minimizing infringement risk.
Q3: What is the importance of the use claims in this patent?
A3: Use claims extend protection to specific therapeutic methods, enabling patent holders to assert rights over treatment applications, which can be crucial in patent litigation and licensing.
Q4: Are the claims likely to withstand patent examination standards?
A4: Given broad claims, the patent’s validity depends on prior art availability. Narrow dependent claims and detailed descriptions enhance defensibility.
Q5: How does the patent landscape influence R&D investments?
A5: Understanding overlapping patents guides R&D direction, avoiding costly infringement disputes while optimizing licensing opportunities.
References
- World Intellectual Property Organization. Patent WO2006023616.
- Industry Patent Databases and Relevant Journal Publications (as applicable).
- National Patent Office Records and Patent Search Reports.
Disclaimer: This analysis is based on publicly available information and assumes typical patent structures. For legal or commercial decisions, consult a patent attorney or IP expert.
